GTS Securities LLC Sells 3,638 Shares of SPDR S&P Biotech ETF $XBI

GTS Securities LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.5% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,482 shares of the exchange traded fund’s stock after selling 3,638 shares during the quarter. GTS Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $3,400,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of XBI. Avoro Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $256,053,000. Bank of America Corp DE raised its position in SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the period. Wells Fargo & Company MN raised its position in SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after purchasing an additional 1,536,122 shares during the period. OMERS ADMINISTRATION Corp lifted its stake in SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after purchasing an additional 1,187,907 shares during the last quarter. Finally, Morgan Stanley lifted its stake in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $162.38 on Friday. SPDR S&P Biotech ETF has a 1 year low of $89.33 and a 1 year high of $169.89. The business has a 50 day simple moving average of $156.78 and a two-hundred day simple moving average of $139.13. The firm has a market capitalization of $10.60 billion, a PE ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.